INTERNATIONAL REMAP-CAP TRIAL SAYS INITIAL ANALYSIS SHOWS CONVALESCENT PLASMA DID NOT IMPROVE OUTCOMES FOR CRITICALLY ILL COVID-19 PATIENTS
International Remap-Cap Trial Says Initial Analysis Shows Convalescent Plasma Did Not Improve Outcomes For Critically Ill Covid-19 Patients
![Reuters logo](/images/reuters.jpg)